Biogen Inc. buy hoffi69
Start price
08.05.12
/
50%
€101.61
Target price
23.10.12
€110.00
Performance (%)
7.22%
End price
23.10.12
€108.95
Summary
This prediction ended on 23.10.12 with a price of €108.95. With a performance of 7.22%, the BUY prediction by hoffi69 for Biogen Inc. closed with a slight gain. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 2.372% | 2.372% | 54.860% | -23.684% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt sich auch in unruhigen Börsenzeiten einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)